Results 241 to 250 of about 425,993 (391)

Peer-Delivered Outreach With Rapid Treatment Pathways for Hepatitis C Testing and Treatment Among Unhoused People. [PDF]

J Viral Hepat
Vojt G, Bonnet P, Scott J, Hathorn E, Ellis L, Bufton S, Mutimer D, Buchanan R, Reid L, Morris D, Elsharkawy A.   +10 more
europepmc   +1 more source

Comparative evaluation of first- and second-generation anti-hcv assays for screening tests of donated blood: The relationship between their sensitivities and donor's age, GPT levels and transfusion histories.

, 1993
Shuji Awakihara, Masayuki Miyahara, Masaaki Chikayuki, Eiichi Uchiyama, Hiromasa Sato, Kanji Miyamoto   +5 more
openalex   +2 more sources

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States

Journal of Acquired Immune Deficiency Syndromes, 2016
Michelle M. Van Handel, C. Rose, E. Hallisey, J. Kolling, Jon E. Zibbell, B. Lewis, Michele K. Bohm, Christopher M. Jones, Barry Flanagan, Azfar-e-Alam Siddiqi, K. Iqbal, A. Dent, J. Mermin, E. McCray, J. Ward, J. Brooks   +15 more
semanticscholar   +1 more source

Tumor Endothelial Cells Induce M2 Macrophage Polarization via IL‐4, Enhancing Tumor Growth in Hepatocellular Carcinoma

Cancer Science, EarlyView.
Tumor endothelial cells (TECs) promote the polarization of macrophages to M2 subtype by secreting IL‐4. Downregulation of IL‐4 in TECs suppressed M2 polarization and tumor progression. A high abundance of both TECs and M2 macrophages in HCC specimens is associated with poor prognosis.
Daijiro Matoba, Takehiro Noda, Shogo Kobayashi, Yoshihiro Sakano, Kenichi Matsumoto, Chihiro Yamanaka, Kazuki Sasaki, Shinichiro Hasegawa, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Hidenori Takahashi, Tadafumi Asaoka, Junzo Shimizu, Hisashi Wada, Yuichiro Doki, Hidetoshi Eguchi   +17 more
wiley   +1 more source

Small Molecule Targeting of Atypical p38 Protects Against Viral Infection. [PDF]

FASEB J
Royer FT, Burton JC, Burns J, Lloyd MG, Onwe R, Moffat JF, Grimsey NJ.   +6 more
europepmc   +1 more source

Epidemiology of hepatitis C in central Portugal. Prevalence of anti-HCV in the population of the Coimbra District.

, 1994
Alexandra F. Santos, Armando Carvalho, Daniela Bento, R Sá, J. Tomaz, Vítor Rodrigues, L Pais, Aurélia F. Porto   +7 more
openalex   +1 more source

Study of HCV RNA and several HCV antibodies in chronically hemodialized patients.

, 1994
Hitomi Yokoyama, Takahide Noguchi, Tsutomu Tanaka, Itsuko Kuriyama, Katsumi Ueno, Tomonori Segawa, Takuma Aoyama, Arihiro Hattori, Toshiya Kin, Akihisa Kunishima, Noriyasu Mori, Hiroshi Araki, Eiichi Tomita   +12 more
openalex   +2 more sources

Reprimo (RPRM): A Tumor Suppressor That Induces Extrinsic Apoptosis via YAP Signaling

Cancer Science, EarlyView.
Reprimo (encoded by RPRM) is a p53 target gene that acts as a tumor suppressor and is frequently silenced by promoter hypermethylation in various cancers. Although previously known to function intracellularly as a tumor suppressor, recent studies revealed that secreted Reprimo also induces apoptosis in neighboring cells through a novel p53‐Reprimo ...
Masahiro Takikawa, Rieko Ohki
wiley   +1 more source

Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain. [PDF]

PLoS One
Chivite I, Guilera V, Callau P, Aguiló R, de Lazzari E, Merino MJ, Diaz L, Carrodeguas A, González-Sánchez JL, Mallolas J.   +9 more
europepmc   +1 more source

An availability of HCV-core antibody determination.The study in HCV antibody electropositive case in a mass examination.

, 1993
AKIHIKO URUSHIBARA
openalex   +2 more sources